02:00 Fri 15 Jan 2021
Deepverge PLC - Completion of Compulsory Acquisition; TVR

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. IN PARTICULAR, THIS ANNOUNCEMENT SHOULD NOT BE RELEASED, PUBLISHED, DISTRIBUTED, FORWARDED OR TRANSMITTED, IN WHOLE OR IN PART, IN, INTO OR FROM ANY RESTRICTED JURISDICTION, INCLUDING THE US.
RECOMMENDED ALL SHARE OFFER
for
MODERN WATER PLC
by
DEEPVERGE PLC
COMPLETION OF COMPULSORY ACQUISITION
On
As at
Compulsory acquisition
Further to DeepVerge's announcement on
Share allotment
The Company has today allotted 3,636,915 New DeepVerge Shares in respect of the Modern Water Shares compulsorily acquired, and application will be made for these shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at
Total Voting Rights
The Company's total issued share capital, following the issue of the new Ordinary Shares, will be 169,514,211 ordinary shares of
Enquiries
DeepVerge plc | | Contact via DeepVerge's PR
|
SPARK Advisory Partners Limited (Nominated Adviser)
| | +44 (0) 113 370 8974 |
Turner Pope Investments (TPI) Limited (Broker) | | +44 (0) 20 3657 0050 |
Mo PR (Financial PR adviser to DeepVerge)
|
|
+44 (0) 7876 444977 |
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE